Zzbiotech
Houston, US · 1 known investors
ZZ Biotech develops 3K3A-APC, a genetically engineered variant of human activated protein C (a serine protease) optimized for therapeutic use. The company has agreed in principle to license its 3K3A-APC dermatology program to Dermatherix for wound therapy applications.
Biotech